- Home
- Gastrointestinal Oncology
- Biomarker-Driven Treatment of Gastric, Esophageal, and Gastroesophageal Junction Cancers

20223 min read
Medical Article
Gastric cancer is one of the most common cancers in the world. It is also among the cancers with high mortality rate. Both the Gastric and Esophageal cancer the more common in males although dependent on various factors such as diet, ethnicity, Infectious agents (like EBV, Helicobacter, etc). Genomic characterization of these cancers are also done

Biomarker-Driven Treatment of Gastric, Esophageal, and Gastroesophageal Junction Cancers
414 Reached
Similar Content

Black Lesion in Old Female
1970 Reached5 Comments11 Likes

Study evaluating Effectiveness of Bacillus clausii for Treatment of Rotavirus Infection
1303 Reached4 Comments6 Likes

Case of Increased Risk of Pregnancy-associated Breast Cancer Recurrence
1007 Reached2 Comments

Treatment of Recurrent Adult Medulloblastoma
2601 Reached1 Comments4 Likes

Management of Metastatic Prostate Cancer
1037 Reached5 Comments2 Likes